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Abstract
Background: Recurrent pregnancy loss (RPL), defined as 3 or more consecutive miscarriages, is widely attributed either to
repeated chromosomal instability in the conceptus or to uterine factors that are poorly defined. We tested the hypothesis
that abnormal cyclic differentiation of endometrial stromal cells (ESCs) into specialized decidual cells predisposes to RPL,
based on the observation that this process may not only be indispensable for placenta formation in pregnancy but also for
embryo recognition and selection at time of implantation.
Methodology/Principal Findings: Analysis of mid-secretory endometrial biopsies demonstrated that RPL is associated with
decreased expression of the decidual marker prolactin (PRL) but increased levels of prokineticin-1 (PROK1), a cytokine that
promotes implantation. These in vivo findings were entirely recapitulated when ESCs were purified from patients with and
without a history of RPL and decidualized in culture. In addition to attenuated PRL production and prolonged and enhanced
PROK1 expression, RPL was further associated with a complete dysregulation of both markers upon treatment of ESC
cultures with human chorionic gonadotropin, a glycoprotein hormone abundantly expressed by the implanting embryo. We
postulated that impaired embryo recognition and selection would clinically be associated with increased fecundity, defined
by short time-to-pregnancy (TTP) intervals. Woman-based analysis of the mean and mode TTP in a cohort of 560 RPL
patients showed that 40% can be considered ‘‘superfertile’’, defined by a mean TTP of 3 months or less.
Conclusions: Impaired cyclic decidualization of the endometrium facilitates implantation yet predisposes to subsequent
pregnancy failure by disabling natural embryo selection and by disrupting the maternal responses to embryonic signals.
These findings suggest a novel pathological pathway that unifies maternal and embryonic causes of RPL.
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Introduction
Miscarriage is the most common complication of pregnancy. It
is estimated that 30% of embryos are lost prior to implantation
(pre-implantation loss) and a further 30% before 6 weeks
gestation (pre-clinical/biochemical pregnancy loss) [1]. In
addition, in excess of 10% of clinical pregnancies result in
miscarriage, mostly prior to 12 weeks gestation, and 1–2% of
couples experience recurrent pregnancy loss (RPL), defined as
failure of 3 or more consecutive pregnancies [2]. Beside the
physical trauma, miscarriage, and especially RPL, is associated
with considerable psychological morbidity with a third of patients
attending specialist clinics suffering from clinical depression [2].
Moreover, a history of RPL increases the risk of a variety of
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adverse obstetric outcomes in a subsequent ongoing pregnancy,
including preterm delivery, premature preterm rupture of
membranes, placenta praevia, low birth weight and congenital
malformation [3].
Early pregnancy loss is widely viewed as a dichotomous
disorder, attributed either to maternal factors or chromosomal
errors in the conceptus. On the maternal side, numerous
anatomical, endocrine, immunological, thrombophilic and genetic
perturbations have been invoked to explain RPL, yet none are
specific or prevalent [2,3]. Moreover, for most of these conditions,
the pathological mechanisms that account for persistent pregnancy
wastage are entirely conjectural. Conversely, between 30 to 60%
of miscarriages are attributed to fetal chromosomal anomalies [4].
These estimates are based on conventional karyotyping of fetal
tissues, suggesting that the true incidence may be higher.
However, the prevalence of gross mitotic chromosomal errors in
preimplantation human embryos is also very high, affecting a
staggering 90% of all embryos, even in young fertile women [5]. In
other words, if chromosomal instability in the preimplantation
embryo is the norm rather than the exception, then RPL could
primarily reflect inadequate embryo selection, accounting for the
high prevalence of aneuploidic miscarriages.
For most of the menstrual cycle, the endometrium is not primed
for implantation. It only transiently acquires a receptive
phenotype, starting approximately 6 days after the postovulatory
progesterone surge and is estimated to last between 2 to 4 days
[6,7]. Arguably, a limited ‘implantation window’ synchronizes
implantation with embryo development, which may serve as an
important mechanism to select against developmentally impaired
but potentially invasive embryos. Consistent with this concept, the
population study of Wilcox et al [7] elegantly demonstrated that
implantation beyond the normal period of endometrial receptivity
is strongly associated with early pregnancy loss.
Although the luminal endometrial epithelium is the primary
barrier in the implantation process, the progesterone responses in
this cellular compartment that underpin the receptive phenotype
are mediated by signals derived from the underlying stromal cells
[8]. A striking feature of the human endometrium is that the
acquisition of a receptive phenotype in the mid-secretory phase of
the cycle coincides with decidualization of the stromal compart-
ment, irrespective of pregnancy. Decidualization is characterized
by transient local oedema, influx of macrophages and specialized
uterine natural killer cells, angiogenesis, and the extraordinary
transformation of resident endometrial stromal fibroblasts into
secretory, epitheloid-like decidual cells [9–11]. From a functional
perspective, the decidual process is indispensable for pregnancy in
all species with invasive placentae as it establishes maternal
immunologic tolerance to fetal antigens, protects the conceptus
against environmental insults, and ensures tissue integrity and
haemostasis during the process of trophoblast invasion and
placenta formation [9,10]. Further, decidualization of human
endometrial stromal cells also bestows on the endometrium the
ability to selectively recognize and respond to developmentally
impaired embryos, as outlined in the accompanying paper by
Teklenburg et al. in this journal.
Based on these observations, we hypothesized that impaired
decidualization of the endometrium prior to conception predis-
poses for subsequent pregnancy failure, either by prolonging the
implantation window, thereby disabling natural embryo selection,
or by disrupting the maternal responses to embryonic signals. If
correct, impaired decidualization and lack of natural embryo
selection should not only lead to RPL but also be associated with
paradoxical superfecundity, defined by persistent very short time-
to-pregnancy (TTP) intervals.
Results
Endometrial Decidualization Is Impaired in RPL
We speculated that impaired decidualization of the stromal
compartment may facilitate delayed implantation of compromised
embryos by prolonging the window of endometrial receptivity, as
suggested by the population study of Wilcox et al [7]. To test this
hypothesis, we determined the expression levels of a recently
identified key regulator of endometrial receptivity, prokineticin-1
(PROK1) [12], as well as prolactin (PRL), a classic decidual
marker [11,13]. Transcript levels were determined in endometrial
biopsies, timed to span the implantation window, from RPL
patients and controls, consisting of either fertile or infertile women
without a history of recurrent pregnancy failure (Table S1).
Compared with controls, RPL was associated with significantly
higher endometrial PROK1 mRNA levels and approximately
100-fold lower PRL levels (Fig. 1A & B). Analysis of an
independent sample set (Table S2) demonstrated that elevated
PROK1 transcript levels are primarily associated with biochemical
rather than fetal RPL, whereas no such association was found with
PRL (Fig. 1C & D).
To validate these in vivo observations, we established primary
cultures from 9 RPL patients and 12 controls (Table S3). ESCs,
purified from samples taken randomly in the cycle, were passaged
once, allowed to grow to confluency, and then decidualized over a
time-course lasting 8 days. PROK1 and PRL mRNA levels did not
differ between the two groups in undifferentiated ESCs or in cells
decidualized for 48 hours. However, after 4 days of differentiation,
the rise in PRL transcript levels was several magnitudes higher in
the control group when compared to RPL samples (Fig. 2).
PROK1 levels continued to rise with comparable kinetics in all
decidualizing cultures until day 8 when expression in the control
but not RPL group declined markedly.
This expression profile in cultured cells supported the notion
that an impaired decidual response, leading to prolonged
endometrial receptivity and impaired embryo selection, is the
primary uterine defect in RPL. Two additional observations are
worth emphasizing. First, the magnitude of difference in PROK1
and PRL expression between the RPL and control group was not
only high, at mRNA as well as at the secreted protein level (Fig.
S1), but the pattern of expression in all samples corresponded to
the clinical phenotype. Secondly, ESCs were purified from
endometrial samples taken randomly in the cycle and maintained
in prolonged culture, suggesting that the ability to mount a
decidual response, perhaps more so than the signals responsible for
differentiation, is perturbed in RPL.
hCG Responses in Decidual Cells Are Disrupted in RPL
We speculated that aberrant differentiation of ESCs observed in
RPL patients would interfere directly with the maternal response
to embryonic signals. To test this hypothesis, we examined the
effects of human chorionic gonadotropin (hCG), one of the earliest
and most abundant glycoproteins secreted by embryonic tropho-
blast, on PRL and PROK1 expresssion in 20 additional cultures
(Table S4). ESCs were decidualized with 8-Br-cAMP and MPA for
72 hours in the presence or absence of hCG. As reported
previously [14], hCG strongly inhibited PRL mRNA levels in all
control cultures (Fig. 3A). In contrast, this response was without
exception reversed in RPL samples and characterized by a modest
but significant increase in PRL transcripts upon hCG treatment.
PROK1 mRNA levels were also inhibited by approximately 50%
upon hCG treatment of decidualizing control cultures whereas the
opposite response, a 4-fold increase, was observed in RPL cultures
(Fig. 3B). The data suggest that perturbed endometrial preparation
Impaired Decidual Cells in RPL
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prior to conception will have profound consequences on embryo-
maternal interactions in pregnancy.
RPL Is Associated with Short Time-To-Pregnancy
RPL patients often report short periods between pregnancies,
which is the predictable clinical correlate of impaired embryo
recognition and selection. To substantiate this observation, we
analysed the time-to-pregnancy (TTP), expressed in months, in
2076 pregnancies reported by 560 women with a history of 3 or
more consecutive miscarriages. Woman-based analysis of the
mean and mode TTP showed that many RPL patients are highly
fecund (Fig. 4 and Table S5). Multivariate logistic regression
analysis demonstrated that fecundity is further enhanced in the
subgroup of patients with 5 or more recurrent miscarriages (odds
ratio: 2.0; 95% confidence interval 1.1–3.4; P=0.01 when
adjusted for maternal age). In the absence of a suitable control
group, we compared the observed incidence of achieving 3 or
more pregnancies within 1, 3, or 6 months with the predicted
likelihoods, based on an average MFR of 20% [15]. As shown in
Table 1, the observed incidence of persistent short TTP intervals
in RPL patients was much higher than predicted. In fact, 40% of
RPL patients could be considered ‘superfertile’, defined by a mean
TTP of less than 3 months [15]. Interestingly, maternal age was
not an important confounding factor for TTP in RPL patients,
which further suggests that implantation, rather than fertilization,
is the major rate-limiting step in the fecundity of fertile couples.
Discussion
Our study provides compelling evidence that impaired decidual
programming of the endometrium is an important mechanism
underlying RPL. This is based primarily on the observation that
expression of PRL, a highly sensitive and specific decidual marker
gene in the endometrium [13,16], is grossly impaired in RPL
patients, both in vivo as well in primary cultures subjected to a
decidualizing stimulus. However, we also obtained evidence that
uterine receptivity is enhanced and prolonged in RPL patients,
which in turn may facilitate delayed implantation of compromised
embryos. Differentiating ESCs abundantly express PROK1, a
cytokine that promotes embryo-uterine interaction via induction of
leukaemia inhibitory factor (LIF) in endometrial epithelial cells
[12]. The levels of this pro-implantation cytokine were signifi-
cantly higher in timed endometrial samples from RPL patients,
especially in women with a history of predominantly very early
(biochemical) pregnancy losses. More strikingly, the induction of
PROK1 in decidualizing endometrial cultures from control
women was transient, with levels declining after 4 days of
differentiation, whereas the levels continued to rise in cultures
established from RPL patients. The concept of enhanced
endometrial receptivity in RPL is supported by a previous study
demonstrating that affected women express lower levels of mucin
1, an anti-adhesion molecule that contributes to the barrier
function of luminal epithelium [4,17].
Figure 1. PROK1 and PRL transcript levels in timed endometrial samples of 10 RPL patients and 20 control (CON) subjects,
consisting of 10 fertile (FERT) volunteers and 10 infertile (INF) patients without a history of RPL. PROK1 (A) and PRL (B) mRNA levels,
normalized to L19 transcript levels, are expressed in arbitrary units (a.u.). Horizontal bars indicate the median expression in each group. PROK1 and
PRL mRNA levels, respectively (C & D), in RPL patients with recurrent biochemical (biochem; n = 10) or fetal (n = 10) pregnancy failure. A ‘biochemical’
loss was defined as a miscarriage at 4–6 weeks gestation with ultrasound evidence of either an intrauterine pregnancy sac with no fetus or retained
products of conception. A ‘fetal’ loss was defined as a pregnancy failure between 6–13 weeks gestation with prior ultrasound evidence of fetal
development. Note the logarithmic y-axes.
doi:10.1371/journal.pone.0010287.g001
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We also found that RPL is further associated with paradoxical
endometrial responses to embryonic hCG signalling, characterized
by induction rather than inhibition of PRL and PROK1
expression in decidualizing ESCs. The ability of hCG to inhibit
decidual PRL expression is in agreement with a previous study
[14]. Interestingly, hCG has been shown to transiently induce
PROK1 in Ishikawa cells, a cancer cell line widely used as model
for uterine epithelial cells, which was followed by increased LIF
expression [12]. Combined with our data, these observations
indicate that under normal circumstances, hCG signalling may
first transiently enhance uterine receptivity upon contact of the
embryo with the luminal epithelium but upon implantation
antagonize continuous receptivity by inhibiting decidual PROK1.
The mechanism of normal hCG signaling in decidual cells remains
to be defined [18], which is a prerequisite for understanding the
disrupted transcriptional responses in RPL. Irrespective of the
underlying pathway, a dysregulated response in pregnancy is likely
to jeopardize the integrity of the feto-maternal interface as hCG,
besides its luteotrophic role in early pregnancy, directly stimulates
angiogenesis and limits cell death responses in the maternal
decidua [19–21].
Although our expression analysis was confined to PRL and
PROK1, the data demonstrate that endometrial programming in
preparation of pregnancy is both quantitatively and qualitatively
different in RPL, characterized by impaired decidualization of
resident stromal cells, prolonged endometrial receptivity and a
dysregulated maternal response to embryonic signals. This
pathological pathway explains several established clinical features
of RPL. For example, in view of the excess of chromosomally
abnormal preimplantation human embryos [5], the likelihood of
euploidic pregnancy failure can be predicted to increase with the
number of miscarriages, which is indeed the case [22]. As
mentioned, failure to limit the window of endometrial receptivity
also accounts for delayed implantation of severely compromised
embryos and subsequent very early pregnancy loss [7]. A primary
defect in the decidual response may further explain why the
Figure 2. RPL is associated with aberrant expression of PROK1 and PRL in decidualizing primary ESC cultures. PROK1 (A) and PRL (B)
mRNA levels, normalized to L19 transcript levels and expressed in arbitrary units (a.u.), were determined in undifferentiated ESCs (day 0) or cultures
decidualized with 8-Br-cAMP and MPA (cAMP/MPA) for 2, 4 or 8 days. A total of 9 primary cultures were established from RPL patients and 12 from
control (CON) subjects. Horizontal bars indicate the median expression in each group. Note the logarithmic y-axes.
doi:10.1371/journal.pone.0010287.g002
Figure 3. RPL is characterised by aberrant hCG responses in
decidualizing ESCs. Primary cultures from RPL patients (n = 10) and
control women (n = 10) were decidualized with 8-Br-cAMP and MPA for
72 hours in the presence or hCG or vehicle. The data show the
percentage change (6 SEM) in PRL (A) and PROK1 (B) mRNA levels upon
hCG treatment of control and RPL cultures, relative to the expression
levels in cultures treated with vehicle (dotted lines); P,0.005.
doi:10.1371/journal.pone.0010287.g003
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incidence of miscarriage drops dramatically after 12 weeks
gestation [2]. The last few weeks of the first trimester of pregnancy
are particularly perilous for the conceptus as it coincides with
intense vascular remodelling, the onset of placental perfusion, and
a dramatic increase in oxygen tension at the feto-maternal
interface [23]. Reactive oxygen species trigger a pro-apoptotic
pathway in undifferentiated ESCs, which is selectively silenced
upon differentiation into decidual cells [24]. Thus an adequate
decidual response is critical to prevent cell death, necrosis, and
bleeding at the feto-maternal interface, especially when challenged
by oxidative stress signals towards the end of the first trimester.
Finally, the concept of defective embryo selection explains why
some RPL patients appear to be exceptionally fertile.
Biologic fertility is measured using TTP [25]. Based on an
average MFR of 20%, a simple mathematical model predicts that
74%, 93%, and 100% of normally fertile couples will conceive in 6,
12, and 24 months, respectively [15]. Along the same lines,
moderate and severe subfertility are defined by MFR of 5% and
1%, respectively. On the other side of the spectrum is superfertility,
characterized by a MFR of 60% or more. In this context, the term
‘superfertility’ refers to enhanced efficacy in achieving pregnancy
but not increased life-births. Superfertile couples achieve 94% and
100% of pregnancies within 3 and 6 months, respectively [15]. It
has been estimated that 79% of the population is fertile, 18%
subfertile or infertile, and 3% superfertile [15,26]. Our retrospective
analysis of TTP revealed that 40% of RPL patients report very short
time to conception for each pregnancy. Thus, the prevalence of
‘superfertile’ couples in this population appears to be considerably
higher than expected. Arguably, a majority of patients did not, or at
least not consistently, report very short TTPs but this is not
unexpected as the likelihood of conception is dependent upon many
additional variables, including timing and frequency of coitus and
the presence of coexisting disorders, such as suboptimal sperm
quality or ovulatory, tubal and uterine defects. Hence, additional
well-controlled, prospective studies are warranted to test our
assumption that the superfertile end of the fecundity spectrum is
as much a pathological condition as subfertility.
A striking observation is that the aberrant expression of PRL and
PROK1 in timed endometrial biopsies from RPL patients is
recapitulated upon differentiation of purified ESCs maintained in
prolonged cultures. Such cellular ‘memory’ suggests that the
endometrial decidual response is subject to epigenetic programming
in humans [9]. Interestingly, inflammatory signals are important
epigenetic modifiers [27], which raises the possibility that the tissue
trauma associated with pregnancy loss, or even menstrual events
between pregnancies, may provide cues that dynamically modulate
subsequent decidual responses in the endometrium [9]. If the
epigenetic basis of RPL is correct than profiling of DNA or histone
modifications in endometrial biopsies could be used to identify
women at risk of adverse pregnancy outcome prior to conception
and to monitor the effectiveness of medical interventions.
In summary, decidualization of uterine tissues is indispensable
for placenta formation in pregnancy. We now provide evidence
that failure to express an adequate decidual phenotype disables
embryo recognition and selection upon implantation, which may
lead to shorter TTP intervals but also predisposes to persistent
pregnancy failure. Established risk factors for RPL, such as
antiphospholipid antibodies and endocrine perturbations, may
directly impact on uterine function, although our data suggest that
the primary defect lies in the ability of ESCs to mount a decidual
response. Together, these findings establish a novel pathological
pathway that unifies maternal and embryonic causes of RPL.
Materials and Methods
Ethics statement and patient selection
The Research Ethics Committee of each participating centre
approved the study: Hammersmith and Queen Charlotte’s &
Chelsea Research Ethics Committee (1997/5065) and the Liver-
pool (Adult) Research Ethics Committee (REC reference number:
05/Q1505/147). Written informed consent was obtained from all
participating subjects. All patients were investigated according to
the standard clinic protocols [28], but the outcome of these routine
Figure 4. Woman-based analysis of time-to-pregnancy (TTP) in 560 women with a history of $3 consecutive first trimester
miscarriages. Histogram representing woman-based analysis of the mean (A) and mode (B) TTP in patients with RPL.
doi:10.1371/journal.pone.0010287.g004
Table 1. Proportion of women achieving $3 consecutive
pregnancies within 1, 3, or 6 months.
1 month 3 months 6 months
Predicted: 0.8% 8% 41%
RPL patients: 13% 41% 68%
Predicted likelihoods are based on a MFR of 20%; P,0.0001.
doi:10.1371/journal.pone.0010287.t001
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investigations was not taken in account in either the recruitment
into this study or in the analysis of the data.
Timed endometrial biopsies
Women were asked to use commercially available urine LH kits
and to contact the research team at the time of their LH surge. All
samples were obtained 6–10 days after the LH surge with a pipelle
sampling device. Each biopsy was divided and one portion snap-
frozen in liquid nitrogen for RNA analysis. The other portion was
fixed in formalin for histological dating using standard criteria.
The demographic details of the RPL and control groups are
summarize in Tables S1 & S2.
Analysis of the decidual response in vitro
Primary ESC cultures were established from endometrial
biopsies, taken randomly in the cycle, as previous described
[29]. The demographic details of RPL and control patients are
summarized in Table S3. Primary cultures were passaged once,
allowed to grow to confluency, and then decidualized with 8-Br-
cAMP (0.5 mM) and MPA (1026 M) for 2, 4 or 8 days. At each
time-point, supernatants were collected and frozen and cells
harvested for mRNA analysis. Additional cultures were established
from control and RPL patients (Table S4) and decidualized with 8-
Br-cAMP and MPA for 72 hours in the presence or absence of
10 nM hCG (Sigma, UK).
PROK1 and PRL measurements
Total RNA was extracted from frozen tissue or cell cultures
using Trizol Reagent (Invitrogen, Paisley, UK), treated with
DNAseI (Ambion, Inc., Austin, TX), reversed transcribed, and the
resulting cDNA subjected to real-time quantitative PCR analysis
using an ABI Prism 7700 Sequence Detection System (Applied
Biosystems, Foster City, CA) with the following gene-specific
primer pairs: L19-sense (59-GCG GAA GGG TAC AGC AAT-39)
and L19-antisense (59-GCA GCC GGC GCA AA-39); PRL-sense
(59-AAG CTG TAG AGA TTG AGG AGC AAA C-39) and
PRL-antisense (59-TCA GGA TGA ACC TGG CTG ACT A-39);
PROK1-sense(59-GTG CCA CCC CGG CAG-39) and PROK1-
antisense (59-AGC AAG GAC AGG TGT GGT GC-39). Secreted
PROK1 and PRL levels were determined using ELISAs (R&D
systems, Abingdon, UK).
Time-to-pregnancy (TTP) analysis
Woman-based analysis of TTP was performed on a cohort of
patients attending a tertiary service level Recurrent Miscarriage
Clinic at Imperial College Healthcare NHS Trust. TTP for each
pregnancy was recorded by medical staff on a standardised pro
forma questionnaire upon referral to the clinic. TTP data of 856
women, encompassing 4018 pregnancies, were extracted from the
clinical notes and subjected to analysis. After excluding incomplete
data sets, the final analysis was based on 560 fertile women with a
history of 3 or more miscarriages, which included 132 patients
with 5 or more miscarriages. All analyses, carried out using
STATA statistical software (Version 10), were adjusted for
maternal age at time of pregnancy. Sensitivity analyses excluding
women with other pregnancy complications (e.g. ectopic preg-
nancy, terminations and multiple pregnancies) showed similar
effects. The unit of analysis was a pregnancy.
Statistical analyses
Student’s t-test and Mann-Whitney U test were used to determine
statistical significance between two groups. For multiple compari-
sons, ANOVA test with Bonferroni correction was used. P,0.05
was considered significant. The association between the relevant
pregnancy outcome and TTP was explored using logistic regression
analysis, with effects on risk being estimated by odds ratios with 95%
confidence intervals. Since women could have more than one
pregnancy outcome in the analysis, a robust method based on the
‘‘sandwich estimate’’ [30] was used to compute standard errors, with
Wald tests to ascertain statistical significance of parameters [31].
Supporting Information
Figure S1 RPL is associated with impaired PROK1 and PRL
secretion by decidualizing ESCs. Secreted PROK1 (A) and PRL
(B) levels accumulated over 48 hours in the supernatants of
confluent primary ESC cultures decidualization with 8-Br-cAMP
and MPA for 8 days. Primary cultures were established from 10
RPL patients and 10 control (CON) subjects. Horizontal bars
indicate the median expression in each group.
Found at: doi:10.1371/journal.pone.0010287.s001 (0.61 MB EPS)
Table S1 Analysis of timed endometrial biopsies - patient
characteristics. The data presented are mean 6 standard
deviation. * indicates P,0.001.
Found at: doi:10.1371/journal.pone.0010287.s002 (0.03 MB
DOC)
Table S2 Analysis of fetal versus biochemical RPL - patient
characteristics. The data presented are mean 6 standard
deviation. * indicates P,0.05. A ‘fetal’ loss was defined as a
pregnancy failure between 6–13 weeks gestation with prior
ultrasound evidence of fetal development. A ‘biochemical’ loss
was defined as a miscarriage at 4–6 weeks gestation with
ultrasound evidence of either an intrauterine pregnancy sac with
no fetus or retained products of conception.
Found at: doi:10.1371/journal.pone.0010287.s003 (0.03 MB
DOC)
Table S3 Time-course analysis - patient and culture character-
istics. The data presented are mean6 standard deviation. LMP =
last menstrual period. * indicates P,0.001.
Found at: doi:10.1371/journal.pone.0010287.s004 (0.03 MB
DOC)
Table S4 hCG analysis - patient characteristics. The data
presented are mean 6 standard deviation. LMP = last menstrual
period. * indicates P,0.001.
Found at: doi:10.1371/journal.pone.0010287.s005 (0.03 MB
DOC)
Table S5 Analysis of time-to-pregnancy (TTP) in women with
RPL. SD = standard deviation; NS = not significant.
Found at: doi:10.1371/journal.pone.0010287.s006 (0.03 MB
DOC)
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